JPRN-UMIN000002578Recruiting未知
Microdosing cinical studies -Assesment of oral bioavailability of drugs by cassete IV and PO dosing- - Cassete microdosing study for assement of bioavailability using 3 calcium antagonisits
Oita university hospital,Clinical pharmacology center0 sites8 target enrollmentStarted: October 3, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 8
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 40years-old (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)person who has present and/or past history of disease of heart and circulatory system, liver,kidney and uretary system, and digestive system. 2)person who has drug adiction and/or allergy 3)person who takes drugs which has an effect on the result of this study 4)person who is thoght by medical doctor as unsuitable in physical examinations and blood and biochemistry examinations. 5)person who takes drugs and/or health food product like St.John's wort within 7 days before taking study drugs 6)person who juice wfruit within 7 days before taking study drugs including grapefruitjuice 7)person who usually take health food product like St.John's wort 8)person who joined other clinical study within 3 months before this study and is thougt as unsuitable by medical doctor 9)person who donated blood of 200mL within one month and within 3 months before this study 10)person who is positive HBV,HCV,HIV and syphilis 11)person who has allergy of drug and/or food 12)person who addict drugs and alcohol 12)person who is diagonosed by medical doctors as unsuitable for joinining this study
Investigators
Similar Trials
Completed
Not Applicable
Microdosing cinical studies -Assessment of enteric coated drugsHealthy AdultJPRN-UMIN000004844Oita university hospital, Clinical pharmacology center16
Completed
Not Applicable
Microdose (intravenous and oral) and oral dose of S 47445 to assess absolute bioavailability, pharmacokinetic parameters and excretion balance of S 47445 in healthy young male volunteers.Alzheimer's diseasedementiaNL-OMON36963Institut de Recherches Internationales Servier I.R.I.S6
Completed
Not Applicable
Microdose (i.v.) and oral potential therapeutic dose administration of S 47445 to assess absolute bioavailability and pharmacokinetic parameters of S 47445 in healthy young male volunteers. An open label 1 period study.Alzheimer's DiseaseNL-OMON34318Institut de Recherches Internationales Servier I.R.I.S4
Completed
Phase 1
Clinical study for PET microdose method by oral dose of [11C]Telmisartan in healthy volunteersHealthy male subjectsJPRN-UMIN000004990Foundation for Biomedical Research and Innovation10
Completed
Early Phase 1
Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine CompoundsMalariaNCT03436160U.S. Army Medical Research and Development Command18